BIO-SOURCING
0554.840.790 · rovalta.com · 25/09/2026
ACTIVE
BIO-SOURCING
Financial year 2025 · Closed on 31/12/2025
Net result-1,2 M €-2 309,8 %over 1 year
Gross margin1,6 M €-34,2 %over 1 year
Equity894,8 k €+10,0 %over 1 year
Workforce17,3 ETP+28,1 %over 1 year
Overview
Identity
Source · BCE/KBOBIO-SOURCING is a Public limited company incorporated in 2014. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Liège. It employs on average 17,3 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0554.840.790
- Incorporation
- 27/06/2014
- Legal form
- Public limited company
- Registered office
- Boulevard du Rectorat 27 B box Bat. B22
4000 Liège · WallonieSee on map - Contributed capital
- 94 239,59 €
- Latest accounts
- 31/12/2025
- Average workforce
- 17,3 ETP
Activities (NACE)
Joint committees (2)
- 116
- 207
Signals
Good liquidityHealthy social debts
Financials
Source · NBB, 14 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,6 M € | -34.2% | 2,4 M € | +30.0% | 1,9 M € | +78.3% | 1 M € | +52.3% | 682 k € |
| EBITDA | -522,4 k € | -162% | 836,3 k € | +3.1% | 811,2 k € | +6593% | 12,1 k € | +355% | -4,7 k € |
| Operating result | -1,1 M € | -1572% | -65,9 k € | +76.3% | -277,4 k € | -146% | -112,9 k € | -2.2% | -110,5 k € |
| Net result | -1,2 M € | -2310% | -48,6 k € | +77.8% | -219,3 k € | -58.0% | -138,8 k € | -13.5% | -122,3 k € |
| Balance sheet | |||||||||
| Equity | 894,8 k € | +10.0% | 813,5 k € | +103% | 401,1 k € | -35.3% | 620,4 k € | -18.3% | 759,2 k € |
| Total assets | 6,6 M € | +12.9% | 5,8 M € | +34.4% | 4,3 M € | +9.6% | 4 M € | -33.4% | 5,9 M € |
| Cash | 2 M € | -52.3% | 4,2 M € | +26.2% | 3,3 M € | +64.3% | 2 M € | -50.9% | 4,1 M € |
| Debts | 5,4 M € | +46.5% | 3,7 M € | +38.6% | 2,6 M € | +178% | 948,5 k € | -7.6% | 1 M € |
| Other | |||||||||
| Workforce | 17,3 ETP | +28.1% | 13,5 ETP | +18.4% | 11,4 ETP | +17.5% | 9,7 ETP | +22.8% | 7,9 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20259 active · 38 ended
Active mandates
Quentin JANSSENS DE VAREBEKE
ActiveActive
Eric MAREE
ActiveMichel GOLDMAN
ActiveMichel HELBIG DE BALZAC
ActiveActive
Philippe JANSSENS DE VAREBEKE
ActiveEQUITY GESTION SAS
ActiveEnded mandates
Other companies at this address
Boulevard du Rectorat 27 B 4000 Liège| Company | CBE no. |
|---|---|
CapriGen Animal Health● Active | 1030.602.729 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/07/2026 | 01/07/2025 | 04/07/2024 | 04/07/2023 | 14/07/2022 | 08/07/2021 |
| General meeting | 19/06/2026 | 23/06/2025 | 26/06/2024 | 03/05/2023 | 04/05/2022 | 24/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 19/06/2026 | 15/07/2026 | French | |
| Abridged model | 31/12/2024 | 23/06/2025 | 01/07/2025 | French | |
| Abridged model | 31/12/2023 | 26/06/2024 | 04/07/2024 | French | |
| Abridged model | 31/12/2022 | 03/05/2023 | 04/07/2023 | French | |
| Abridged model | 31/12/2021 | 04/05/2022 | 14/07/2022 | French | |
| Abridged model | 31/12/2020 | 24/06/2021 | 08/07/2021 | French | |
| Abridged modelCorrection | 31/12/2019 | 06/05/2020 | 23/09/2020 | French | |
| Abridged model | 31/12/2019 | 06/05/2020 | 27/08/2020 | French | |
| Abridged modelCorrection | 31/12/2018 | 02/05/2019 | 20/04/2020 | French | |
| Abridged model | 31/12/2018 | 02/05/2019 | 10/07/2019 | French | |
| Abridged model | 31/12/2017 | 02/05/2018 | 10/07/2018 | French | |
| Abridged model | 31/12/2016 | 22/05/2017 | 04/07/2017 | French | |
| Abridged model | 31/12/2015 | 04/05/2016 | 30/06/2016 | French | |
| Abridged model | 31/12/2014 | 21/05/2015 | 24/08/2015 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20259 active · 38 ended
Active mandates
Quentin JANSSENS DE VAREBEKE
ActiveActive
Eric MAREE
ActiveMichel GOLDMAN
ActiveMichel HELBIG DE BALZAC
ActiveActive
Philippe JANSSENS DE VAREBEKE
ActiveEQUITY GESTION SAS
ActiveEnded mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates14/07/2026DEMISSIONS, NOMINATIONS
- Restructuring09/12/2025CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring15/10/2025RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates11/02/2025DEMISSIONS, NOMINATIONS
- Mandates19/12/2022DEMISSIONS, NOMINATIONS
- Registered office24/12/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - SIEGE SOCIAL - OBJET
- Mandates25/08/2021DEMISSIONS, NOMINATIONS
- Capital / shares23/06/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-1,2 M €↓
- 2024Annual accounts 2024-48,6 k €↑
- 2023Annual accounts 2023-219,3 k €↓
- 2022Annual accounts 2022-138,8 k €↓
- 2021Annual accounts 2021-122,3 k €↓
- 2020Annual accounts 2020-28,9 k €↑
- 2019Annual accounts 2019-1,1 M €↑
- 2018Annual accounts 2018-1,4 M €↓
- 2017Annual accounts 2017-1,2 M €↑
- 2016Annual accounts 2016-1,2 M €↓
- 2015Annual accounts 2015-878,8 k €
- 27/06/2014IncorporationPublic limited company